{"id":789,"date":"2024-09-24T04:59:54","date_gmt":"2024-09-24T02:59:54","guid":{"rendered":"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/"},"modified":"2024-09-24T04:59:56","modified_gmt":"2024-09-24T02:59:56","slug":"une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques","status":"publish","type":"post","link":"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/","title":{"rendered":"Une charge de comorbidit\u00e9 plus \u00e9lev\u00e9e associ\u00e9e \u00e0 de moins bons r\u00e9sultats cliniques dans la scl\u00e9rose en plaques"},"content":{"rendered":"<div>\n<div class=\"article-gallery lightGallery\">\n<div data-thumb=\"https:\/\/scx1.b-cdn.net\/csz\/news\/tmb\/2024\/higher-burden-of-comor.jpg\" data-src=\"https:\/\/scx2.b-cdn.net\/gfx\/news\/2024\/higher-burden-of-comor.jpg\" data-sub-html=\"\">\n<figure class=\"article-img\">\n<\/figure><\/div>\n<\/div>\n<p>Pour les personnes atteintes de scl\u00e9rose en plaques (SEP), une charge plus \u00e9lev\u00e9e de comorbidit\u00e9 est associ\u00e9e \u00e0 de moins bons r\u00e9sultats cliniques, selon une \u00e9tude publi\u00e9e en ligne le 18 septembre dans <i>JAMA Neurologie<\/i> pour co\u00efncider avec la r\u00e9union annuelle du Comit\u00e9 europ\u00e9en pour le traitement et la recherche sur la scl\u00e9rose en plaques, qui se tient du 18 au 20 septembre \u00e0 Copenhague, au Danemark.<\/p>\n<p>Amber Salter, Ph.D., du UT Southwestern Medical Center de Dallas, et ses coll\u00e8gues ont examin\u00e9 l&rsquo;association entre les comorbidit\u00e9s et l&rsquo;activit\u00e9 de la maladie dans les essais cliniques de th\u00e9rapies modificatrices de la maladie chez des populations atteintes de SEP dans le cadre d&rsquo;une approche m\u00e9ta-analytique en deux \u00e9tapes. L&rsquo;\u00e9tude de cohorte comprenait les donn\u00e9es individuelles de 16 794 participants atteints de SEP issus de 17 essais cliniques de phase 3 de th\u00e9rapies modificatrices de la maladie.<\/p>\n<p>Les chercheurs ont constat\u00e9 que 61,0 % des essais regroup\u00e9s pr\u00e9sentaient des signes d&rsquo;activit\u00e9 de la maladie (EDA) au cours de la p\u00e9riode de suivi de deux ans. Apr\u00e8s ajustement pour plusieurs facteurs, par rapport \u00e0 l&rsquo;absence de comorbidit\u00e9, la pr\u00e9sence de trois comorbidit\u00e9s ou plus \u00e9tait associ\u00e9e \u00e0 un risque accru d&rsquo;EDA (rapport de risque ajust\u00e9, 1,14).<\/p>\n<p>Le risque d&rsquo;EDA \u00e9tait \u00e9galement accru en pr\u00e9sence de deux ou plusieurs troubles cardiom\u00e9taboliques par rapport \u00e0 l&rsquo;absence de ces troubles (rapport de risque ajust\u00e9, 1,21). Un risque accru d&rsquo;EDA a \u00e9t\u00e9 observ\u00e9 en association avec un trouble psychiatrique (rapport de risque ajust\u00e9, 1,07).<\/p>\n<p>\u00ab Comme ces r\u00e9sultats sont coh\u00e9rents avec les \u00e9tudes observationnelles utilisant des mod\u00e8les d\u2019\u00e9tude et des sources de donn\u00e9es diff\u00e9rents, les preuves sugg\u00e8rent que les cliniciens doivent syst\u00e9matiquement aborder la comorbidit\u00e9 chez les personnes atteintes de SEP \u00bb, \u00e9crivent les auteurs.<\/p>\n<p>Plusieurs auteurs ont r\u00e9v\u00e9l\u00e9 des liens avec l\u2019industrie biopharmaceutique ; l\u2019\u00e9tude s\u2019est bas\u00e9e sur des recherches utilisant des donn\u00e9es provenant de soci\u00e9t\u00e9s pharmaceutiques.<\/p>\n<p>                                        <!-- print only --><\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Pour les personnes atteintes de scl\u00e9rose en plaques (SEP), une charge plus \u00e9lev\u00e9e de comorbidit\u00e9<\/p>\n","protected":false},"author":1,"featured_media":790,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[86],"tags":[76,68,986,443,987,44,963,67,770,69,769,47],"class_list":["post-789","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-les-maladies","tag-associee","tag-bons","tag-charge","tag-cliniques","tag-comorbidite","tag-dans","tag-elevee","tag-moins","tag-plaques","tag-resultats","tag-sclerose","tag-une","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50","resize-featured-image"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Une charge de comorbidit\u00e9 plus \u00e9lev\u00e9e associ\u00e9e \u00e0 de moins bons r\u00e9sultats cliniques dans la scl\u00e9rose en plaques - RVH-Synergie.org<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Une charge de comorbidit\u00e9 plus \u00e9lev\u00e9e associ\u00e9e \u00e0 de moins bons r\u00e9sultats cliniques dans la scl\u00e9rose en plaques - RVH-Synergie.org\" \/>\n<meta property=\"og:description\" content=\"Pour les personnes atteintes de scl\u00e9rose en plaques (SEP), une charge plus \u00e9lev\u00e9e de comorbidit\u00e9\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/\" \/>\n<meta property=\"og:site_name\" content=\"RVH-Synergie\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-24T02:59:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-24T02:59:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1727146795_Une-charge-de-comorbidite-plus-elevee-associee-a-de-moins.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Charles Martinez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Charles Martinez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/\"},\"author\":{\"name\":\"Charles Martinez\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\"},\"headline\":\"Une charge de comorbidit\u00e9 plus \u00e9lev\u00e9e associ\u00e9e \u00e0 de moins bons r\u00e9sultats cliniques dans la scl\u00e9rose en plaques\",\"datePublished\":\"2024-09-24T02:59:54+00:00\",\"dateModified\":\"2024-09-24T02:59:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/\"},\"wordCount\":363,\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1727146795_Une-charge-de-comorbidite-plus-elevee-associee-a-de-moins.jpg\",\"keywords\":[\"associ\u00e9e\",\"bons\",\"charge\",\"cliniques\",\"comorbidit\u00e9\",\"dans\",\"\u00e9lev\u00e9e\",\"moins\",\"plaques\",\"r\u00e9sultats\",\"scl\u00e9rose\",\"une\"],\"articleSection\":[\"Les maladies\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/\",\"name\":\"Une charge de comorbidit\u00e9 plus \u00e9lev\u00e9e associ\u00e9e \u00e0 de moins bons r\u00e9sultats cliniques dans la scl\u00e9rose en plaques - RVH-Synergie.org\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1727146795_Une-charge-de-comorbidite-plus-elevee-associee-a-de-moins.jpg\",\"datePublished\":\"2024-09-24T02:59:54+00:00\",\"dateModified\":\"2024-09-24T02:59:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/#primaryimage\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1727146795_Une-charge-de-comorbidite-plus-elevee-associee-a-de-moins.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1727146795_Une-charge-de-comorbidite-plus-elevee-associee-a-de-moins.jpg\",\"width\":1280,\"height\":720,\"caption\":\"Une charge de comorbidit\u00e9 plus \u00e9lev\u00e9e associ\u00e9e \u00e0 de moins bons r\u00e9sultats cliniques dans la scl\u00e9rose en plaques\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/rvh-synergie.org\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Une charge de comorbidit\u00e9 plus \u00e9lev\u00e9e associ\u00e9e \u00e0 de moins bons r\u00e9sultats cliniques dans la scl\u00e9rose en plaques\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"name\":\"RVH-Synergie.org\",\"description\":\"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.\",\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\",\"name\":\"RVH-Synergie.org\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"width\":512,\"height\":512,\"caption\":\"RVH-Synergie.org\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\",\"name\":\"Charles Martinez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"caption\":\"Charles Martinez\"},\"description\":\"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.\",\"sameAs\":[\"https:\/\/rvh-synergie.org\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Une charge de comorbidit\u00e9 plus \u00e9lev\u00e9e associ\u00e9e \u00e0 de moins bons r\u00e9sultats cliniques dans la scl\u00e9rose en plaques - RVH-Synergie.org","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/","og_locale":"fr_FR","og_type":"article","og_title":"Une charge de comorbidit\u00e9 plus \u00e9lev\u00e9e associ\u00e9e \u00e0 de moins bons r\u00e9sultats cliniques dans la scl\u00e9rose en plaques - RVH-Synergie.org","og_description":"Pour les personnes atteintes de scl\u00e9rose en plaques (SEP), une charge plus \u00e9lev\u00e9e de comorbidit\u00e9","og_url":"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/","og_site_name":"RVH-Synergie","article_published_time":"2024-09-24T02:59:54+00:00","article_modified_time":"2024-09-24T02:59:56+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1727146795_Une-charge-de-comorbidite-plus-elevee-associee-a-de-moins.jpg","type":"image\/jpeg"}],"author":"Charles Martinez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Charles Martinez","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/#article","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/"},"author":{"name":"Charles Martinez","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560"},"headline":"Une charge de comorbidit\u00e9 plus \u00e9lev\u00e9e associ\u00e9e \u00e0 de moins bons r\u00e9sultats cliniques dans la scl\u00e9rose en plaques","datePublished":"2024-09-24T02:59:54+00:00","dateModified":"2024-09-24T02:59:56+00:00","mainEntityOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/"},"wordCount":363,"publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1727146795_Une-charge-de-comorbidite-plus-elevee-associee-a-de-moins.jpg","keywords":["associ\u00e9e","bons","charge","cliniques","comorbidit\u00e9","dans","\u00e9lev\u00e9e","moins","plaques","r\u00e9sultats","scl\u00e9rose","une"],"articleSection":["Les maladies"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/","url":"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/","name":"Une charge de comorbidit\u00e9 plus \u00e9lev\u00e9e associ\u00e9e \u00e0 de moins bons r\u00e9sultats cliniques dans la scl\u00e9rose en plaques - RVH-Synergie.org","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/#primaryimage"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1727146795_Une-charge-de-comorbidite-plus-elevee-associee-a-de-moins.jpg","datePublished":"2024-09-24T02:59:54+00:00","dateModified":"2024-09-24T02:59:56+00:00","breadcrumb":{"@id":"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/#primaryimage","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1727146795_Une-charge-de-comorbidite-plus-elevee-associee-a-de-moins.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/1727146795_Une-charge-de-comorbidite-plus-elevee-associee-a-de-moins.jpg","width":1280,"height":720,"caption":"Une charge de comorbidit\u00e9 plus \u00e9lev\u00e9e associ\u00e9e \u00e0 de moins bons r\u00e9sultats cliniques dans la scl\u00e9rose en plaques"},{"@type":"BreadcrumbList","@id":"https:\/\/rvh-synergie.org\/actualites\/une-charge-de-comorbidite-plus-elevee-associee-a-de-moins-bons-resultats-cliniques-dans-la-sclerose-en-plaques\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/rvh-synergie.org\/actualites\/"},{"@type":"ListItem","position":2,"name":"Une charge de comorbidit\u00e9 plus \u00e9lev\u00e9e associ\u00e9e \u00e0 de moins bons r\u00e9sultats cliniques dans la scl\u00e9rose en plaques"}]},{"@type":"WebSite","@id":"https:\/\/rvh-synergie.org\/actualites\/#website","url":"https:\/\/rvh-synergie.org\/actualites\/","name":"RVH-Synergie.org","description":"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.","publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/rvh-synergie.org\/actualites\/#organization","name":"RVH-Synergie.org","url":"https:\/\/rvh-synergie.org\/actualites\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","width":512,"height":512,"caption":"RVH-Synergie.org"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560","name":"Charles Martinez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","caption":"Charles Martinez"},"description":"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.","sameAs":["https:\/\/rvh-synergie.org\/"]}]}},"_links":{"self":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/comments?post=789"}],"version-history":[{"count":0,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/789\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media\/790"}],"wp:attachment":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media?parent=789"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/categories?post=789"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/tags?post=789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}